Zymogen
WikiDoc Resources for Zymogen |
Articles |
---|
Most recent articles on Zymogen |
Media |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Zymogen at Clinical Trials.gov Clinical Trials on Zymogen at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Zymogen
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Directions to Hospitals Treating Zymogen Risk calculators and risk factors for Zymogen
|
Healthcare Provider Resources |
Causes & Risk Factors for Zymogen |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Overview
A zymogen (or proenzyme) is an inactive enzyme precursor. A zymogen requires a biochemical change (such as a hydrolysis reaction revealing the active site, or changing the configuration to reveal the active site) for it to become an active enzyme. The biochemical change usually occurs in a lysosome where a specific part of the precursor enzyme is cleaved in order to activate it. The amino acid chain that is released upon activation is called the activation peptide.
Etymology
Very often the suffix "-ogen" can be added to the name of the enzyme to indicate that it is in the precursor form. Some enzymes have a pro- prefix to denote their inactive status e.g. Proalbumin, which is converted into albumin. [1]
Examples
Examples of zymogens:
- Trypsinogen
- Chymotrypsinogen
- Pepsinogen
- Most proteins in the coagulation system
- Some of the proteins of the complement system
- Caspases
- Proelastase
- Prolipase
See also
cs:Zymogen
da:Zymogen
de:Zymogen
he:זימוגן
Template:Jb1
Template:WH
Template:WikiDoc Sources